YMAB vs. MPTI

In the year-to-date period, YMAB achieves a 18.91% return, which is significantly lower than MPTI's 37.56% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Y-mAbs Therapeutics, Inc. (YMAB) and M-tron Industries Inc (MPTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current YMAB Sharpe Ratio is 0.39, which is lower than the MPTI Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of YMAB and MPTI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither YMAB nor MPTI has paid dividends to shareholders.

The maximum YMAB drawdown since its inception was -94.78%, which is greater than MPTI's maximum drawdown of -46.41%. Use the drawdown chart below to compare losses from any high point for YMAB and MPTI. For additional features, visit the drawdowns tool.

Y-mAbs Therapeutics, Inc. (YMAB) and M-tron Industries Inc (MPTI) have volatilities of 20.03% and 20.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Y-mAbs Therapeutics, Inc. and M-tron Industries Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.